The peptide's gastric stability further enables oral-administration designs that are not feasible with most peptide research compounds
Theyve also been shown to be a helpful tool against food noise, reducing the overwhelming mental chatter about food that many people experience
Discontinuation due to factors typically irrelevant in clinical trial settings (i.e., cost or insurance-related issues and medication shortages) could contribute to the substantial discrepancy between discontinuation rates in pivotal phase 3 trials and those reported in real-world studies. Regarding discontinuation due to side effects, Gasoyan says we do not currently know of patient-level predictors that would help identify who might experience side effects and why
Weight loss, enhanced insulin sensitivity, and reduction in inflammatory stressors create a physiologic milieu conducive to normal gonadal function
Results from a phase 2 randomized, placebo-controlled trial of liraglutide (1.23.0 mg) in 564 obese non-diabetic adults demonstrated that liraglutide 3.0 mg was statistically significantly more effective than orlistat, or diet and exercise alone, at reducing weight over 20 and 52 weeks, and weight loss was dose-dependent